Skip to main content

Want a detailed portfolio tracker?

vTv Therapeutics (VTVT) P/E (2020 - 2026)

vTv Therapeutics (VTVT) P/E from Mar 31, 2020 to Jun 3, 2026. The TTM vTv Therapeutics (VTVT) P/E is -8.00. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of vTv Therapeutics (VTVT)

YearP/EChange
2026-8.00-17.63%
2025-9.71+201.99%
2024-3.22+277.31%
2023-0.85-46.24%
2022-1.59-53.04%
2021-3.38-48.00%
2020-6.49N/A

Comparison vTv Therapeutics (VTVT) P/E with competitors

vTv Therapeutics (VTVT) P/E is -8.00.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-101.28%
ENLVEnlivex Therapeutics Ltd0.15-101.88%
FGENFibroGen Inc0.24-103.00%
TRAWTraws Pharma Inc0.47-105.91%
FBIOFortress Biotech Inc0.71-108.83%
CHRSCoherus Biosciences Inc0.98-112.23%
ORMPOramed Pharmaceuticals Inc1.47-118.42%
AGENAgenus Inc2.05-125.61%
VIVSVivoSim Labs Inc2.54-131.70%
INVAInnoviva Inc3.19-139.86%
CRMDCorMedix Inc3.65-145.58%
ABEOAbeona Therapeutics Inc4.20-152.57%
CVACCureVac N.V.4.45-155.58%
SRPTSarepta Therapeutics Inc4.62-157.81%
GLPGGalapagos NV4.86-160.74%
RIGLRigel Pharmaceuticals4.92-161.50%
ZVRAZevra Therapeutics Inc4.97-162.18%
ABUSArbutus Biopharma Corp5.69-171.18%
CGENCompugen Ltd7.38-192.31%
AUPHAurinia Pharmaceuticals Inc9.25-215.66%
ACADAcadia Pharmaceuticals Inc9.59-219.87%
OMEROmeros Corporation9.88-223.56%
PLXProtalix BioTherapeutics Inc9.91-223.88%
SPROSpero Therapeutics Inc10.73-234.20%
ADMAAdma Biologics Inc11.33-241.65%
SVASinovac Biotech Ltd11.44-242.97%
TBPHTheravance Biopharma Inc11.78-247.23%
HRMYHarmony Biosciences Holdings Inc12.18-252.28%
TGTXTG Therapeutics Inc13.18-264.77%
INCYIncyte Corp13.38-267.30%
SABSSAB Biotherapeutics Inc14.06-275.75%
XOMAXOMA Corp14.95-286.84%
REGNRegeneron Pharmaceuticals Inc14.98-287.28%
PBYIPuma Biotechnology Inc15.05-288.16%
EXELExelixis Inc15.79-297.46%
NAGENiagen Bioscience Inc16.35-304.47%
CPRXCatalyst Pharmaceuticals Inc17.34-316.84%
MDXGMimedx Group Inc17.38-317.22%
ARGXArgen X SE23.07-388.44%
HALOHalozyme Therapeutics Inc23.20-390.05%
XOMAOXOMA Corp25.34-416.86%
VRTXVertex Pharmaceuticals Inc25.66-420.74%
XOMAPXOMA Corp25.67-420.92%
CTMXCytomX Therapeutics Inc25.70-421.27%
ASNDAscendis Pharma A/S26.35-429.47%
RPRXRoyalty Pharma plc - Class A27.50-443.74%
SLNOSoleno Therapeutics Inc29.02-462.75%
LGNDLigand Pharmaceuticals Inc - Class B30.19-477.39%
BMRNBiomarin Pharmaceutical Inc37.51-568.91%
APLSApellis Pharmaceuticals Inc39.02-587.84%
KRYSKrystal Biotech Inc39.70-596.29%
GMABGenmab40.20-602.62%
ONCBeiGene Ltd67.03-937.96%
TECHBio-Techne Corp68.59-957.57%
VCELVericel Corp80.63-1108.02%
PHARPharming Group N.V.87.74-1196.92%
ALNYAlnylam Pharmaceuticals Inc124.93-1661.90%
TLXTelix Pharmaceuticals Ltd139.89-1848.89%
CORTCorcept Therapeutics Inc158.39-2080.16%